Q4 2021 Eton Pharmaceuticals Inc Earnings Call Transcript
Good evening, and welcome to the Eton Pharmaceuticals fourth-quarter 2021 financial and operating results conference call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call up to your questions. Please be advised that this call is being recorded at the company's request.
At this time, I'd like to turn [the call] over to David Krempa, Senior Vice President of Business Development and Investor Relations at Eton Pharmaceuticals. Please proceed.
Thank you, operator. Good evening, everyone, and welcome to Eton's fourth-quarter 2021 conference call. This afternoon, we issued a press release that outlines the topics we plan to discuss on today's call. The release is available on our website, etonpharma.com.
Joining me on the call today, we have Sean Brynjelsen, our CEO; Wilson Troutman, our CFO; and Kevin Guthrie, our Executive Vice President of Commercial Activities.
In addition to taking live questions
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |